Screener
Upstream Bio, Inc. UPB Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 36,089 | 37,865 | 72,654 | 63,662 |
| General and administrative | 7,052 | 7,419 | 15,136 | 14,201 |
| Total operating expenses | 43,141 | 45,284 | 87,790 | 77,863 |
| Loss from operations | (42,368) | (44,347) | (85,983) | (76,360) |
| Other income (expense): | ||||
| Interest income | 2,659 | 4,431 | 5,713 | 9,174 |
| Other income (expense), net | 7 | (50) | (23) | (50) |
| Total other income, net | 2,666 | 4,381 | 5,690 | 9,124 |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s operating income?
- Upstream Bio, Inc. (UPB) reported operating income of -$42.37M in Q2 2026.
- How has Upstream Bio, Inc.'s operating income changed year-over-year?
- Upstream Bio, Inc.'s operating income increased by 4.5% year-over-year, from -$44.35M to -$42.37M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Upstream Bio, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude